Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel uses for antidiuresis.

H Hashim1, P Abrams

  • 1Bristol Urological Institute, Southmead Hospital, Westbury on Trym, Bristol, UK. hashim@doctors.org.uk

International Journal of Clinical Practice. Supplement
|October 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial urinary sphincter surgery in the UK: are we following the guidelines?

Annals of the Royal College of Surgeons of England·2025
Same author

Are We Able to Optimize Outcomes and Predict Complications in Pelvic Floor Surgery With a Better Understanding of Hormonal, Microbial and Other Factors? A Report From the ICI-RS 2024.

Neurourology and urodynamics·2024
Same author

Evaluation of Central Sensitisation in Bladder Pain Syndrome: A Systematic Review.

International urogynecology journal·2024
Same author

Diffusion-weighted imaging in hyperacute haemorrhagic stroke patients presenting within thrombolysis window.

The Medical journal of Malaysia·2023
Same author

The Effect of Pre-operative use of Antiplatelets and Anticoagulants on Time to Surgery in Hip Fracture Patients.

Malaysian orthopaedic journal·2023
Same author

Proper understanding of recurrent stress urinary incontinence treatment in women (PURSUIT): a randomised controlled trial of endoscopic and surgical treatment.

Trials·2022
Same journal

Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.

International journal of clinical practice. Supplement·2015
Same journal

Efficacy and safety of basiliximab in liver transplantation for patients with hepatitis B virus-related diseases: a single centre study.

International journal of clinical practice. Supplement·2015
Same journal

Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.

International journal of clinical practice. Supplement·2015
Same journal

Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.

International journal of clinical practice. Supplement·2015
Same journal

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.

International journal of clinical practice. Supplement·2015
Same journal

Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.

International journal of clinical practice. Supplement·2015
See all related articles

New research suggests desmopressin may effectively treat overactive bladder (OAB) by reducing urine production. This antidiuresis approach offers a promising alternative to invasive therapies for OAB patients.

Area of Science:

  • Urology
  • Nephrology
  • Pharmacology

Background:

  • Overactive bladder (OAB) significantly impacts millions globally, characterized by urgency, incontinence, frequency, and nocturia.
  • Current treatments like lifestyle changes, bladder training, and medications (e.g., antimuscarinics) have limitations, including time commitment, patient stamina requirements, and side effects such as dry mouth and constipation.
  • The need for novel, effective treatments for OAB is critical due to its potentially debilitating nature.

Purpose of the Study:

  • To investigate the efficacy of desmopressin, an antidiuretic agent, as a novel treatment for idiopathic overactive bladder (OAB).
  • To evaluate whether reducing urine production via desmopressin can alleviate OAB symptoms by decreasing bladder filling rate.
  • To assess the potential of desmopressin as a non-invasive therapeutic option for OAB management.

Related Experiment Videos

Main Methods:

  • Two multi-center, multinational randomized placebo-controlled trials were conducted.
  • Participants included individuals suffering from idiopathic overactive bladder (OAB).
  • The primary method involved administering desmopressin to reduce kidney urine production and observing its effect on OAB symptoms.

Main Results:

  • The trials demonstrated promising results in alleviating OAB symptoms through desmopressin treatment.
  • A reduction in urine production led to a decreased rate of bladder filling, correlating with symptom improvement.
  • Minor side effects were reported, but the overall efficacy suggests a viable new treatment avenue.

Conclusions:

  • Desmopressin shows potential as a novel, non-invasive treatment for overactive bladder (OAB).
  • This antidiuresis approach may reduce the need for invasive procedures like botulinum toxin injections, neuromodulation, or surgery.
  • Desmopressin therapy opens possibilities for combination treatments with existing OAB modalities.